Related Experiment Video
Updated: Mar 19, 2026

Capturing Common Fragile Site Breaks by Native γH2A.X ChIP
Published on: January 24, 2025
v-Src Causes Chromosome Bridges in a Caffeine-Sensitive Manner by Generating DNA Damage
Masayoshi Ikeuchi1, Yasunori Fukumoto2, Takuya Honda3
1Department of Biochemistry & Molecular Biology, Kyoto Pharmaceutical University, Kyoto 607-8414, Japan. ky11020@poppy.kyoto-phu.ac.jp.
Abstract:
An increase in Src activity is commonly observed in epithelial cancers. Aberrant activation of the kinase activity is associated with malignant progression. However, the mechanisms that underlie the Src-induced malignant progression of cancer are not completely understood. We show here that v-Src, an oncogene that was first identified from a Rous sarcoma virus and a mutant variant of c-Src, leads to an increase in the number of anaphase and telophase cells having chromosome bridges. v-Src increases the number of γH2AX foci, and this increase is inhibited by treatment with PP2, a Src kinase inhibitor. v-Src induces the phosphorylation of KAP1 at Ser824, Chk2 at Thr68, and Chk1 at Ser345, suggesting the activation of the ATM/ATR pathway. Caffeine decreases the number of cells having chromosome bridges at a concentration incapable of inhibiting Chk1 phosphorylation at Ser345. These results suggest that v-Src induces chromosome bridges via generation of DNA damage and the subsequent DNA damage response, possibly by homologous recombination. A chromosome bridge gives rise to the accumulation of DNA damage directly through chromosome breakage and indirectly through cytokinesis failure-induced multinucleation. We propose that v-Src-induced chromosome bridge formation is one of the causes of the v-Src-induced malignant progression of cancer cells.
Insights
The oncogenic protein v-Src promotes chromosome bridges in cancer cells by causing DNA damage and activating the ATM/ATR pathway. This suggests v-Src-induced chromosome bridges contribute to malignant progression in epithelial cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Elevated Src activity is common in epithelial cancers and linked to malignant progression.
- Mechanisms of Src-induced cancer progression remain incompletely understood.
Purpose of the Study:
- To investigate the role of v-Src, an oncogene and mutant c-Src, in cancer cell malignant progression.
- To elucidate the mechanisms by which v-Src induces chromosome bridges and DNA damage.
Main Methods:
- Utilized v-Src expression in epithelial cancer cells.
- Assessed chromosome bridges, γH2AX foci, and phosphorylation of KAP1, Chk2, and Chk1.
- Employed Src kinase inhibitor (PP2) and ATM/ATR pathway inhibitor (Caffeine).
Main Results:
- v-Src expression increased chromosome bridges and γH2AX foci, indicating DNA damage.
- v-Src induced phosphorylation of KAP1, Chk2, and Chk1, suggesting ATM/ATR pathway activation.
- Caffeine reduced chromosome bridges without inhibiting Chk1 phosphorylation, implicating DNA damage response.
Conclusions:
- v-Src induces chromosome bridges through DNA damage generation and activation of the ATM/ATR pathway.
- Chromosome bridges contribute to DNA damage accumulation and potentially homologous recombination.
- v-Src-induced chromosome bridge formation is proposed as a driver of malignant progression in cancer cells.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations
Nucleotide Excision Repair
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...

